We are live on ! Find out more
DRIO icon

DarioHealth

12 hedge funds and large institutions have $2.16M invested in DarioHealth in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

17% more capital invested

Capital invested by funds: $1.85M → $2.16M (+$308K)

0% more funds holding

Funds holding: 1212 (0)

0.12% less ownership

Funds ownership: 0.63%0.51% (-0.12%)

Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

DRIO Hedge Fund Activity: Q1 2020 in Review

12 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q1 2020, worth a combined $2.16M — up 17% from $1.85M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new DRIO positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Meitav Investment House, opening a new position worth an estimated $194K. The largest seller was Rockefeller Capital Management, exiting entirely with an estimated $33K sold.

  • 12 institutional investors held DarioHealth (DRIO) as of Q1 2020, unchanged from Q4 2019.
  • Funds reported $2.16M of DarioHealth stock for Q1 2020, up 17% quarter-over-quarter.
  • 5 funds opened new DarioHealth positions in Q1 2020 and 3 closed out, a net change of +2 holders.
  • The largest DarioHealth buyer in Q1 2020 was Meitav Investment House, an estimated $194K added.
  • The largest DarioHealth seller in Q1 2020 was Rockefeller Capital Management, an estimated $33K sold.

Based on aggregated 13F filings for Q1 2020.